Clincosm LogoSign in Get a demo

recurrent prostate cancer

Showing 26 - 50 of 92
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in New Brunswick, Portland

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • ipilimumab
  • laboratory biomarker analysis
  • New Brunswick, New Jersey
  • +1 more
Sep 23, 2020

Recurrent Prostate Cancer Trial in Duarte, South Pasadena (procedure, radiation, other)

Completed
Has Results
  • Recurrent Prostate Cancer
  • computed tomography
  • +6 more
  • Duarte, California
  • +1 more
Aug 26, 2020

Adenocarcinoma of the Prostate, Bone Metastases, Hormone-resistant Prostate Cancer Trial in Duarte, Pasadena, Salt Lake City

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +5 more
  • sipuleucel-T
  • +2 more
  • Duarte, California
  • +2 more
Aug 21, 2020

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial (brachytherapy, image-guided radiation

Withdrawn
  • Adenocarcinoma of the Prostate
  • +4 more
  • brachytherapy
  • +2 more
  • (no location specified)
Jul 23, 2020

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Cleveland (radiation, procedure,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +5 more
  • stereotactic body radiation therapy
  • +2 more
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
May 8, 2020

Bone Metastases, Castrate-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Chicago (drug, other, procedure)

Completed
Has Results
  • Bone Metastases
  • +3 more
  • Chicago, Illinois
    University of Chicago
Mar 25, 2020

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Stanford (drug, radiation,

Completed
  • Adenocarcinoma of the Prostate
  • +5 more
  • sodium selenite
  • +4 more
  • Stanford, California
    Stanford University, School of Medicine
Feb 14, 2020

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Chicago (dietary supplement, other,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +4 more
  • genistein
  • +2 more
  • Chicago, Illinois
    Northwestern University
Aug 27, 2019

Recurrent Prostate Cancer Trial in Canada, United States (High Intensity Focused Ultrasound)

Unknown status
  • Recurrent Prostate Cancer
  • High Intensity Focused Ultrasound
  • Los Angeles, California
  • +15 more
Apr 9, 2019

Hormone-refractory Prostate Cancer, Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer Trial in United States

Completed
Has Results
  • Hormone-refractory Prostate Cancer
  • +4 more
  • Duarte, California
  • +5 more
Feb 5, 2019

Recurrent Prostate Cancer Trial in Atlanta (FACBC)

Completed
Has Results
  • Recurrent Prostate Cancer
  • Atlanta, Georgia
    Emory University Hospital
Dec 12, 2018

Adenocarcinoma of the Prostate, Castration-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Seattle (Cabozantinib)

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +4 more
  • Seattle, Washington
    Seattle Cancer Care Alliance/University of Washington
Nov 6, 2018

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in United States (drug,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Hsp90 inhibitor STA-9090
  • +7 more
  • Baltimore, Maryland
  • +3 more
Aug 19, 2018

Recurrent Prostate Cancer, Stage I Prostate Cancer, Stage IIA Prostate Cancer Trial (moderate exercise intervention, vigorous

Withdrawn
  • Recurrent Prostate Cancer
  • +3 more
  • moderate exercise intervention
  • +7 more
  • (no location specified)
Aug 8, 2018

Hormone Refractory Prostate Cancer, Recurrent Prostate Cancer Trial in Canada, United States (cediranib maleate, dasatinib)

Completed
Has Results
  • Hormone Refractory Prostate Cancer
  • Recurrent Prostate Cancer
  • Peoria, Illinois
  • +7 more
Jul 9, 2018

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Detroit (bevacizumab, laboratory

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +5 more
  • bevacizumab
  • laboratory biomarker analysis
  • Detroit, Michigan
  • +1 more
Jul 1, 2018

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Omaha (lenalidomide,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +2 more
  • Omaha, Nebraska
    University of Nebraska Medical Center
May 7, 2018

Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Duarte (saracatinib, laboratory biomarker analysis)

Completed
Has Results
  • Hormone-resistant Prostate Cancer
  • Recurrent Prostate Cancer
  • Duarte, California
    City of Hope
Mar 21, 2018

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage I Prostate Cancer Trial in Tucson, Los Angeles (metformin HCl,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +4 more
  • metformin hydrochloride
  • +2 more
  • Tucson, Arizona
  • +2 more
Dec 12, 2017

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Philadelphia (Alisertib,

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Philadelphia, Pennsylvania
    Thomas Jefferson University
Nov 8, 2017

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in New Brunswick (,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +2 more
  • placebo
  • +2 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Oct 25, 2017

Recurrent Prostate Cancer Trial in Toronto (MRI-Guided Biopsy)

Completed
  • Recurrent Prostate Cancer
  • MRI-Guided Biopsy
  • Toronto, Ontario, Canada
    University Health Network
Nov 27, 2017

Adenocarcinoma of the Prostate, Recurrent Prostate Cancer, Stage IV Prostate Cancer Trial in San Francisco, Madison

Completed
Has Results
  • Adenocarcinoma of the Prostate
  • +2 more
  • mitoxantrone hydrochloride
  • +2 more
  • San Francisco, California
  • +1 more
Oct 2, 2017

Adenocarcinoma of the Prostate, Hormone-resistant Prostate Cancer, Recurrent Prostate Cancer Trial in Los Angeles (orteronel,

Terminated
Has Results
  • Adenocarcinoma of the Prostate
  • +3 more
  • Los Angeles, California
    USC Norris Comprehensive Cancer Center
Jul 31, 2017

Recurrent Prostate Cancer Trial in San Diego (CyberKnife Radiosurgery)

Unknown status
  • Recurrent Prostate Cancer
  • CyberKnife Radiosurgery
  • San Diego, California
    CybeKnife Centers of San Diego
Jul 18, 2017